Trial
NCT01494584
Study in Pediatric Subjects With Epilepsy
Phase IITERMINATEDREGULATORYConfidence: MEDIUM
Sponsor
GlaxoSmithKline
Collaborators
Bausch Health Americas, Inc.
Condition
Epilepsy
Intervention
ezogabine/retigabine
Why stopped
Terminated after placing the study on hold at the request of the FDA
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-11-30